Path 5: Loss of Proteostasis

Rationale: The garbage catastrophe: proteins misfolding and aggregating. This path tackles aging as a failure of protein quality control. Youthful cells keep their proteins properly folded and degrade damaged proteins via the proteasome and autophagy. With age, these systems decline, leading to misfolded or cross-linked proteins accumulating (amyloid plaques, tau tangles, alpha-synuclein, lipofuscin). Boost the proteostasis network – chaperones, proteasomes, autophagy, breaking cross-links – and we might delay aging.

Prerequisites: Biochemistry (protein structure and folding), cell biology (ubiquitin-proteasome system, autophagy-lysosome pathway).

Dependencies: Overlaps Path 7 (nutrient sensing) because dietary and metabolic interventions often affect proteostasis. Links to Path 6 (mitochondrial) via mitophagy, and to Path 10 (inflammation) via protein aggregates triggering inflammatory responses.

Signs of Progress: Drugs or genetic tweaks that markedly improve proteostasis in old animals and extend their lifespan. Successful clearance of aggregates via immunotherapy. Breaking AGE cross-links in tissues restoring elasticity.

BC5.1: Protein Homeostasis Systems

Scope: Review how cells maintain protein quality. Cover molecular chaperones, ubiquitin-proteasome system, and autophagy-lysosome system.

BC5.2: Age-Related Protein Aggregation

Scope: Study examples of “garbage” that accumulates: lipofuscin, extracellular aggregates (amyloid plaques, senile cardiac amyloid), intracellular aggregates (tau, Lewy bodies), cross-linked ECM proteins.

BC5.3: Autophagy and Longevity

Scope: Focus on autophagy’s role in extending lifespan. CR, mTOR inhibition, spermidine all induce autophagy.

BC5.4: Therapeutics Targeting Proteostasis

Scope: Pharmacological chaperones, proteasome activators, autophagy inducers, cross-link breakers, immunotherapy for aggregates.

Bibliography (Path 5)

← Back to Eiger – Aging Mechanisms